Prevention of blood transfusion with intravenous iron in gynecologic cancer patients receiving platinum-based chemotherapy

Gynecologic Oncology

Volumn 131, Issue 3, 2013, Pages 679-682

  Athibovonsuk, Punnada ^b   Manchana, Tarinee ^a   Sirisabya, Nakarin ^b  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b NONE

Author keywords

Anemia; Blood transfusion; Chemotherapy; Gynecologic cancer; Intravenous iron

Indexed keywords

CARBOPLATIN; FERROUS FUMARATE; HEMOGLOBIN; IRON SACCHARATE; PACLITAXEL;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; ARTICLE; BLOATING; BLOOD CELL COUNT; BLOOD TRANSFUSION; CANCER PATIENT; CONSTIPATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; FEMALE; GYNECOLOGIC CANCER; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; INJECTION SITE PAIN; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; MYALGIA; NAUSEA; NAUSEA AND VOMITING; PATIENT MONITORING; PRIORITY JOURNAL; VOMITING;

ANEMIA; BLOOD TRANSFUSION; CHEMOTHERAPY; GYNECOLOGIC CANCER; INTRAVENOUS IRON;

ANEMIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; FEMALE; FERRIC COMPOUNDS; GENITAL NEOPLASMS, FEMALE; GLUCARIC ACID; HEMATINICS; HEMOGLOBINS; HUMANS; MIDDLE AGED; PACLITAXEL;

EID: 84888301208     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.09.028     Document Type: Article

References (12)

1. H. Ludwig, S. Van Belle, P. Barrett-Lee, G. Birgegard, C. Bokemeyer, and P. Gascon The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients Eur J Cancer 40 2004 2293 2306
2. G. Birgegard, M.S. Aapro, C. Bokemeyer, M. Dicato, P. Drings, and J. Hornedo Cancer-related anemia: pathogenesis, prevalence and treatment Oncology 68 2005 3 11
3. J.E. Groopman, and L.M. Itri Chemotherapy-induced anemia in adults: incidence and treatment J Natl Cancer Inst 91 1999 1616 1634
4. M. Auerbach, H. Ballard, J.R. Trout, M. McIlwain, A. Ackerman, and H. Bahrain Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial J Clin Oncol 22 2004 1301 1307
5. T. Tonia, A. Mettler, N. Robert, G. Schwarzer, J. Seidenfeld, and O. Weingart Erythropoietin or darbepoetin for patients with cancer Cochrane Database Syst Rev 12 Dec 12 2012 CD003407
6. Y.T. Kim, S.W. Kim, B.S. Yoon, H.J. Cho, E.J. Nahm, and S.H. Kim Effect of intravenously administered iron sucrose on the prevention of anemia in the cervical cancer patients treated with concurrent chemoradiotherapy Gynecol Oncol 105 2007 199 204
7. P. Dangsuwan, and T. Manchana Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy Gynecol Oncol 116 2010 522 525
8. G. Weiss, and L.T. Goodnough Anemia of chronic disease N Engl J Med 352 2005 1011 1023
9. K. Munstedt, M. Kovacic, M. Zygmunt, and R. Von Georgi Impact of hemoglobin levels before and during chemotherapy on survival of patients with ovarian cancer Int J Oncol 23 2003 837 843
10. A. Gafter-Gvili, B. Rozen-Zvi, L. Vidal, L. Leibovici, J. Vansteenkiste, and U. Gafter Intravenous iron supplementation for the treatment of chemotherapy induced anaemia-systematic review and meta-analysis of randomized controlled trials Acta Oncol 52 2013 18 29
11. G.R. Bailie, J.A. Clark, C.E. Lane, and P.L. Lane Hypersensitivity reactions and deaths associated with intravenous iron preparations Nephrol Dial Transplant 20 2005 1443 1449
12. E. Luporsi, L. Mahi, C. Morre, J. Wernli, G. de Pouvourville, and R. Bugat Evaluation of cost savings with ferric carboxymaltose in anemia treatment through its impact on erythropoieis-stimulating agents and blood transfusion: French healthcare payer perspective J Med Econ 15 2012 225 232